{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:59:02Z","timestamp":1793681942255,"version":"4.5.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"William and Karen Davidson Fund"},{"name":"Hermelin Brain Tumor Center"},{"name":"Henry Ford Hospital, Detroit"},{"name":"Ministry of Science and Space"},{"name":"Association Duchenne Israel"},{"name":"the Israeli Parents' Duchenne\/Becker Association"},{"name":"Life for Alon Foundation"},{"name":"Science in Action Ltd"},{"name":"ExoStem Biotec, Israel"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.biomaterials.2018.04.055","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T05:50:59Z","timestamp":1525326659000},"page":"67-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":132,"special_numbering":"C","title":["Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy"],"prefix":"10.1016","volume":"174","author":[{"given":"Ariel","family":"Bier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Berenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Kronfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Morgoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amotz","family":"Ziv-Av","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hodaya","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gila","family":"Kazimirsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Cazacu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinat","family":"Meir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachela","family":"Popovtzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Dori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaya","family":"Brodie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2018.04.055_bib1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","article-title":"The muscular dystrophies","volume":"359","author":"Emery","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2018.04.055_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/physrev.00028.2001","article-title":"Function and genetics of dystrophin and dystrophin-related proteins in muscle","volume":"82","author":"Blake","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib4","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008342","article-title":"Building muscle: molecular regulation of myogenesis","volume":"4","author":"Bentzinger","year":"2012","journal-title":"Cold Spring. Harb. Perspect. Biol."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/nm.3990","article-title":"Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division","author":"Dumont","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib6","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/nm.4006","article-title":"A\u00a0new role for dystrophin in muscle stem cells","volume":"21","author":"Keefe","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib7","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature01154","article-title":"Functional improvement of dystrophic muscle by myostatin blockade","volume":"420","author":"Bogdanovich","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2018.04.055_bib8","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/emmm.201302621","article-title":"VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects","volume":"5","author":"Heier","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib9","doi-asserted-by":"crossref","first-page":"H1550","DOI":"10.1152\/ajpheart.01253.2007","article-title":"Functional resolution of fibrosis in mdx mouse dystrophic heart and skeletal muscle by halofuginone","volume":"294","author":"Huebner","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib10","doi-asserted-by":"crossref","first-page":"23249","DOI":"10.18632\/oncotarget.4021","article-title":"Inhibition of muscle fibrosis results in increases in both utrophin levels and the number of revertant myofibers in Duchenne muscular dystrophy","volume":"6","author":"Levi","year":"2015","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.biomaterials.2018.04.055_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/nat.2017.0682","article-title":"Development of exon skipping therapies for Duchenne muscular dystrophy: a critical review and a perspective on the outstanding issues","volume":"27","author":"Aartsma-Rus","year":"2017","journal-title":"Nucl. Acid Therapeut."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00439-016-1725-z","article-title":"Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy","volume":"135","author":"Robinson-Hamm","year":"2016","journal-title":"Hum. Genet."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib13","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/stem.1402","article-title":"A\u00a0new immuno-, dystrophin-deficient model, the NSG-mdx 4Cv mouse, provides evidence for functional improvement following allogeneic satellite cell transplantation","volume":"31","author":"Arpke","year":"2013","journal-title":"Stem Cell."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib14","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nature05282","article-title":"Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs","volume":"444","author":"Sampaolesi","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2018.04.055_bib15","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s12015-014-9537-9","article-title":"Human adipose tissue derived pericytes increase Life span in utrn tm1Ked dmd mdx\/J mice","volume":"10","author":"Valadares","year":"2014","journal-title":"Stem Cell Rev Reports"},{"key":"10.1016\/j.biomaterials.2018.04.055_bib16","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1126\/science.279.5356.1528","article-title":"Muscle regeneration by bone marrow-derived myogenic progenitors","volume":"279","author":"Ferrari","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2018.04.055_bib17","first-page":"715251","article-title":"Preclinical studies with umbilical cord mesenchymal stromal cells in different animal models for muscular dystrophy","volume":"2011","author":"Zucconi","year":"2011","journal-title":"J.\u00a0Biomed. Biotechnol."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib18","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1038\/emm.2013.94","article-title":"Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine","volume":"45","author":"Murphy","year":"2013","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib19","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/jcb.20886","article-title":"Mesenchymal stem cells as trophic mediators","volume":"98","author":"Caplan","year":"2006","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/mt.2011.181","article-title":"Long-term engraftment of multipotent mesenchymal stromal cells that differentiate to form myogenic cells in dogs with Duchenne muscular dystrophy","volume":"20","author":"Nitahara-Kasahara","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib21","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/mus.880181212","article-title":"Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine","volume":"18","author":"Wakitani","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.biomaterials.2018.04.055_bib22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13287-015-0240-9","article-title":"The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy","volume":"6","author":"Zhang","year":"2015","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12929-016-0289-5","article-title":"Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials","volume":"23","author":"Wang","year":"2016","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib24","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1038\/s41598-017-02928-1","article-title":"CXCL12 and osteopontin from bone marrow-derived mesenchymal stromal cells improve muscle regeneration","volume":"7","author":"Maeda","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib25","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1038\/ncomms9472","article-title":"Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs","volume":"6","author":"Phinney","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib26","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.stemcr.2015.04.007","article-title":"Fibrogenic cell plasticity blunts tissue regeneration and aggravates muscular dystrophy","volume":"4","author":"Pessina","year":"2015","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.biomaterials.2018.04.055_bib27","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1089\/scd.2014.0146","article-title":"Mesenchymal stem cells deliver exogenous miRNAs to neural cells and induce their differentiation and glutamate transporter expression","volume":"23","author":"Lee","year":"2014","journal-title":"Stem Cell. Dev."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.18632\/oncotarget.868","article-title":"Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal","volume":"4","author":"Lee","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.biomaterials.2018.04.055_bib29","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/mt.2012.35","article-title":"Loss of miR-29 in myoblasts contributes to dystrophic muscle pathogenesis","volume":"20","author":"Wang","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib30","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1093\/hmg\/ddv381","article-title":"Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration","volume":"24","author":"Roberts","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib31","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93309","article-title":"MicroRNA-29 overexpression by adeno-associated virus suppresses fibrosis and restores muscle function in combination with micro-dystrophin","volume":"2","author":"Heller","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.biomaterials.2018.04.055_bib32","article-title":"Inhibition of miR-29 by TGF-beta-Smad3 signaling through dual mechanisms promotes transdifferentiation of mouse myoblasts into myofibroblasts","volume":"7","author":"Zhou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2018.04.055_bib33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nano.2016.09.013","article-title":"Design principles for noninvasive, longitudinal and quantitative cell tracking with nanoparticle-based CT imaging","volume":"13","author":"Meir","year":"2017","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2044-5040-1-21","article-title":"Aberrant repair and fibrosis development in skeletal muscle","volume":"1","author":"Mann","year":"2011","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.biomaterials.2018.04.055_bib35","first-page":"784","article-title":"Diaphragm degeneration and cardiac structure in mdx mouse: potential clinical implications for Duchenne muscular dystrophy","volume":"228","author":"Barbin","year":"2016","journal-title":"J.\u00a0Anat."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib36","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/hmg\/ddn376","article-title":"Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy","volume":"18","author":"Villalta","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib37","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.yexcr.2006.03.019","article-title":"Immune modulation by mesenchymal stem cells","volume":"312","author":"Rasmusson","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/14712598.2017.1271872","article-title":"Exon skipping: a first in class strategy for Duchenne muscular dystrophy","volume":"17","author":"Niks","year":"2017","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib39","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S1474-4422(16)30035-7","article-title":"Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophy","volume":"15","author":"Straub","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib40","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2017.126","article-title":"Genome engineering: a new approach to gene therapy for neuromuscular disorders","volume":"13","author":"Nelson","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nri.2016.150","article-title":"Regulation of muscle growth and regeneration by the immune system","volume":"17","author":"Tidball","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/icb.2012.56","article-title":"Mechanisms of mesenchymal stromal cell immunomodulation","volume":"91","author":"English","year":"2013","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib43","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.stemcr.2017.04.008","article-title":"MSC-derived extracellular vesicles attenuate immune responses in two autoimmune murine models: type 1 diabetes and uveoretinitis","volume":"8","author":"Shigemoto-Kuroda","year":"2017","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.biomaterials.2018.04.055_bib44","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1089\/scd.2016.0218","article-title":"Different donors mesenchymal stromal cells secretomes reveal heterogeneous profile of relevance for therapeutic use","volume":"26","author":"Assoni","year":"2017","journal-title":"Stem Cell. Dev."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib45","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.expneurol.2011.11.021","article-title":"The functional deficiency of bone marrow mesenchymal stromal cells in ALS patients is proportional to disease progression rate","volume":"233","author":"Koh","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neulet.2012.06.061","article-title":"A\u00a0comparative study of bone marrow mesenchymal stem cell functionality in C57BL and mdx mice","volume":"523","author":"Leng","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib47","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ccr.2012.09.003","article-title":"Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas","volume":"22","author":"Zhang","year":"2012","journal-title":"Canc. Cell"},{"key":"10.1016\/j.biomaterials.2018.04.055_bib48","doi-asserted-by":"crossref","first-page":"15201","DOI":"10.1038\/ncomms15201","article-title":"miR-29b contributes to multiple types of muscle atrophy","volume":"8","author":"Li","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib49","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2008.10.006","article-title":"NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma","volume":"14","author":"Wang","year":"2008","journal-title":"Canc. Cell"},{"key":"10.1016\/j.biomaterials.2018.04.055_bib50","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1128\/MCB.02020-06","article-title":"NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes","volume":"27","author":"Wang","year":"2007","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib51","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/cdd.2016.146","article-title":"MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway","volume":"24","author":"Shu","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib52","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.febslet.2015.03.031","article-title":"Mesenchymal-stem-cell-derived exosomes accelerate skeletal muscle regeneration","volume":"589","author":"Nakamura","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib53","doi-asserted-by":"crossref","unstructured":"Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG, Barnard PJ. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science (80-.). ; 244: 1578\u20131580.","DOI":"10.1126\/science.2662404"},{"key":"10.1016\/j.biomaterials.2018.04.055_bib54","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/CIRCRESAHA.116.308402","article-title":"Duchenne muscular dystrophy mice and men: can understanding a genetic cardiomyopathy inform treatment of other myocardial diseases?","volume":"118","author":"Rafael-Fortney","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib55","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.bbadis.2015.04.013","article-title":"Opposing roles of miR-21 and miR-29 in the progression of fibrosis in Duchenne muscular dystrophy","volume":"1852","author":"Zanotti","year":"2015","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fphys.2012.00049","article-title":"microRNA are central players in anti- and profibrotic gene regulation during liver fibrosis","volume":"3","author":"Noetel","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib57","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0960-8966(94)90070-1","article-title":"Expression of dystrophin-associated glycoproteins during human fetal muscle development: a preliminary immunocytochemical study","volume":"4","author":"Tom\u00e9","year":"1994","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib58","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.bbadis.2018.01.030","article-title":"Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice","volume":"1864","author":"Pisani","year":"2018","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"10.1016\/j.biomaterials.2018.04.055_bib59","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.coph.2017.04.002","article-title":"Pharmacological advances for treatment in Duchenne muscular dystrophy","volume":"34","author":"Guiraud","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.biomaterials.2018.04.055_bib60","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12929-016-0289-5","article-title":"Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials","volume":"23","author":"Wang","year":"2016","journal-title":"J.\u00a0Biomed. Sci."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961218303259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961218303259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:34:34Z","timestamp":1758904474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961218303259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":60,"alternative-id":["S0142961218303259"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2018.04.055","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2018.04.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}